Antitumor Potential of the Isoflavonoids (+)- and (-)-2,3,9-Trimethoxypterocarpan: Mechanism-of-Action Studies

dc.contributor.authorFarias, Kaio
dc.contributor.authorda Costa, Roner F
dc.contributor.authorMeira, Assuero
dc.contributor.authorDiniz-Filho, Jairo
dc.contributor.authorBezerra, Eveline M
dc.contributor.authorFreire, Valder N
dc.contributor.authorGuest, Prudence
dc.contributor.authorNikahd, Maryam
dc.contributor.authorMa, Xing
dc.contributor.authorGardiner, Michael
dc.contributor.authorBanwell, Martin
dc.contributor.authorde Oliveira, Maria da C F
dc.contributor.authorMoraes, Manoel O
dc.contributor.authorPessoa, Claudia
dc.date.accessioned2022-07-13T03:29:47Z
dc.date.issued2020
dc.date.updated2021-08-01T08:22:27Z
dc.description.abstractSynthetically derived samples of (+)-(6aS,11aS)-2,3,9-trimethoxypterocarpan [(+)-1] and its enantiomer [(−)-1], both of which are examples of naturally occurring isoflavonoids, were evaluated, together with the corresponding racemate, as cytotoxic agents against the HL-60, HCT-116, OVCAR-8, and SF-295 tumor cell lines. As a result it was established that compound (+)-1 was particularly active with OVCAR-8 cells being the most sensitive and responding in a dose-dependent manner. A study of cell viability and drug-induced morphological changes revealed the compound causes cell death through a mechanism characteristic of apoptosis. Finally, a computational study of the interactions of compound (+)-1 and (S)-monastrol, an established, synthetically derived, potent, and cell-permeant inhibitor of mitosis, with the kinesin-type protein Eg5 revealed that both bind to this receptor in a similar manner. Significantly, compound (+)-1 binds with greater affinity, an effect attributed to the presence of the associated methoxy groupsen_AU
dc.description.sponsorshipThis study was financed in part by the Coordenaca̧ o de ̃ Aperfeicoamento de Pessoal de Ni ̧ ́ vel Superior - Brasil (CAPES) - Finance Code 001 - CAPES-Print Process nr. 88887.311918/ 2018-00. The authors are grateful to Conselho Nacional de Desenvolvimento Cienti ́ fico e Tecnologico (CNPq) for the ́ financial support of the project (Process nr: 440755/2018-2, 434821/2018-7 and 402329/2013-9) besides the research sponsorships of C. Pessoa (PQ-1B, Process nr: 303102/2013- 6), V. N. Freire (PQ-1B, Process nr: 303771/2007-0), E. M. Bezerra (PQ-2, Process nr: 311563/2017-1) and M. C. F. Oliveira (PQ-2, Process nr: 307667/2017-0). The support of the Australian Research Council and the Institute of Advanced Studies at the Australian National University is also gratefully acknowledged as is the Australian Government for the provision of a Ph.D. scholarship (to PG) and the Islamic Government of Iran for providing travel assistance (to MN).en_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn1948-5875en_AU
dc.identifier.urihttp://hdl.handle.net/1885/268825
dc.language.isoen_AUen_AU
dc.publisherAmerican Chemical Societyen_AU
dc.rights© 2020 American Chemical Societyen_AU
dc.sourceACS Medicinal Chemistry Lettersen_AU
dc.subjectAnticancer agentsen_AU
dc.subjectEg5en_AU
dc.subjectmolecular dockingen_AU
dc.subjectOVCAR-8 cell-lineen_AU
dc.subjectpterocarpanen_AU
dc.titleAntitumor Potential of the Isoflavonoids (+)- and (-)-2,3,9-Trimethoxypterocarpan: Mechanism-of-Action Studiesen_AU
dc.typeJournal articleen_AU
local.bibliographicCitation.issue6en_AU
local.bibliographicCitation.lastpage1280en_AU
local.bibliographicCitation.startpage1274en_AU
local.contributor.affiliationFarias, Kaio, Federal University of Cearaen_AU
local.contributor.affiliationda Costa, Roner F, Federal Rural University of the Semi-Arid Regionen_AU
local.contributor.affiliationMeira, Assuero, Unversidade Federal do Cearaen_AU
local.contributor.affiliationDiniz-Filho, Jairo, Federal University of Cearaen_AU
local.contributor.affiliationBezerra, Eveline M, Federal Rural University of the Semi-Arid Regionen_AU
local.contributor.affiliationFreire, Valder N, Federal University of Cearaen_AU
local.contributor.affiliationGuest, Prudence, College of Science, ANUen_AU
local.contributor.affiliationNikahd, Maryam, College of Science, ANUen_AU
local.contributor.affiliationMa, Xing, College of Science, ANUen_AU
local.contributor.affiliationGardiner, Michael, College of Science, ANUen_AU
local.contributor.affiliationBanwell, Martin, College of Science, ANUen_AU
local.contributor.affiliationde Oliveira, Maria da C F, Federal University of Cearaen_AU
local.contributor.affiliationMoraes, Manoel O, Federal University of Cearaen_AU
local.contributor.affiliationPessoa, Claudia, Universidade Federal do Cearaen_AU
local.contributor.authoremailu1072089@anu.edu.auen_AU
local.contributor.authoruidGuest, Prudence, u4803019en_AU
local.contributor.authoruidNikahd, Maryam, u1059928en_AU
local.contributor.authoruidMa, Xing, u4002198en_AU
local.contributor.authoruidGardiner, Michael, u1072089en_AU
local.contributor.authoruidBanwell, Martin, u9500594en_AU
local.description.embargo2099-12-31
local.description.notesImported from ARIESen_AU
local.identifier.absfor000000 - Internal ANU use onlyen_AU
local.identifier.ariespublicationa383154xPUB13417en_AU
local.identifier.citationvolume11en_AU
local.identifier.doi10.1021/acsmedchemlett.0c00097en_AU
local.identifier.scopusID2-s2.0-85087154680
local.identifier.uidSubmittedBya383154en_AU
local.publisher.urlhttp://pubs.acs.org/journal/amclcten_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Antitumor Potential of the Isoflavonoids.pdf
Size:
6 MB
Format:
Adobe Portable Document Format
Description: